HCA (HCA) earnings
In the quarter ended March 2026, HCA had revenue of $19.1B, up 4.3% on a year earlier, and diluted EPS of 7.15.
On July 24, 2026 it reported EPS of 7.59 against an estimate of 7.57 (beat).
The next report is expected on Tuesday, October 27, 2026 before the market opens, with EPS expected around 6.73.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Tue Oct 27, 2026 | Before open | 6.73 | — |
| Last | Fri Jul 24, 2026 | Before open | 7.57 | 7.59 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from HCA's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | $19.1B | +4.3% | 7.15 | +10.9% | 12.0% | 2026-04-29 |
| Dec 31, 2025 | $19.5B | +6.7% | — | — | 13.7% | 2026-02-10 |
| Sep 30, 2025 | $19.2B | +9.6% | 6.96 | +42.6% | 12.6% | 2025-10-30 |
| Jun 30, 2025 | $18.6B | +6.4% | 6.83 | +23.5% | 13.0% | 2025-08-04 |
| Mar 31, 2025 | $18.3B | +5.7% | 6.45 | +8.8% | 12.7% | 2025-05-01 |
| Dec 31, 2024 | $18.3B | +5.7% | — | — | 11.7% | 2025-02-14 |
| Sep 30, 2024 | $17.5B | +7.9% | 4.88 | +24.8% | 10.9% | 2024-10-31 |
| Jun 30, 2024 | $17.5B | +10.3% | 5.53 | +28.9% | 12.8% | 2024-07-29 |
| Mar 31, 2024 | $17.3B | +11.2% | 5.93 | +22.3% | 13.0% | 2024-05-02 |
| Dec 31, 2023 | $17.3B | +11.7% | — | — | 13.6% | 2024-02-16 |
| Sep 30, 2023 | $16.2B | +8.3% | 3.91 | +0.0% | 10.1% | 2023-10-26 |
| Jun 30, 2023 | $15.9B | +7.0% | 4.29 | +10.0% | 11.4% | 2023-08-02 |
Questions
When does HCA report earnings?
HCA's next earnings report is expected on October 27, 2026 before the market opens.
How did HCA do last quarter?
In the quarter ended March 2026, HCA had revenue of $19.1B, up 4.3% on a year earlier, and diluted EPS of 7.15.
From HCA's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.